Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Via Giustiniani, 2, 35128, Padova, Italy.
J Cardiovasc Transl Res. 2020 Jun;13(3):274-283. doi: 10.1007/s12265-020-09995-2. Epub 2020 Apr 16.
Arrhythmogenic right-ventricular cardiomyopathy (ARVC) is a genetically determined heart disease characterized by progressive myocyte death and substitution by fibrofatty tissue. Life-threatening ventricular arrhythmias may occur during the course of the disease and are distinctively triggered by sports activity: for this reason, ARVC is one of the leading causes of sudden death in the athlete. Early identification of affected athletes by preparticipation screening in the pre-symptomatic phase is essential, but differential diagnosis with the athlete's heart may be challenging. Variants with predominant involvement of the left ventricle are difficult to diagnose unless cardiac magnetic resonance is performed. Athletes with overt ARVC or asymptomatic carriers of pathological gene mutations, including those with an implantable cardioverter defibrillator, should refrain from competitive sports, while a moderate-intensity recreational physical activity appears safe.
致心律失常性右室心肌病(ARVC)是一种由基因突变引起的心脏疾病,其特征为心肌逐渐死亡,并被纤维脂肪组织取代。在疾病进程中可能会发生危及生命的室性心律失常,这些心律失常明显由运动活动触发:出于这个原因,ARVC 是运动员猝死的主要原因之一。通过在无症状期进行参赛前筛查,对患病运动员进行早期识别至关重要,但与运动员心脏相鉴别可能具有挑战性。如果不进行心脏磁共振检查,则很难诊断以左心室为主的病变变异型。患有明显 ARVC 或无症状的病理性基因突变携带者(包括植入式心脏复律除颤器携带者)的运动员应避免竞技运动,而适度强度的娱乐性体育活动似乎是安全的。